#lcsm

LIVE
1.2k

Anya Rossi

sweetdream.ai

SweetDream.aiSponsored•Livecam
Streaming Now

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

HD live stream
Exclusive private shows
1.2k viewers online

Free preview available • Premium content

Lung Cancer Conference Highlights from #ASCO26 w/ Isabel Preeshagul ✅ #LIBRETTO432 ✅ #CROWN (& LORIN) ✅ #CHRYSALIS2 ✅ #HARMONi6 ✅ A quick mention about DeLLphi304 Full 🗣️ ⭐️ OncBrothers & OncUpdates website ⭐️“Oncology Brothers” podcast #OncTwitter #lcsm #MedTwitter
1:36
OncBrothers's profile picture

Lung Cancer Conference Highlights from #ASCO26 w/ Isabel Preeshagul ✅ #LIBRETTO432 ✅ #CROWN (& LORIN) ✅ #CHRYSALIS2 ✅ #HARMONi6 ✅ A quick mention about DeLLphi304 Full 🗣️ ⭐️ OncBrothers & OncUpdates website ⭐️“Oncology Brothers” podcast #OncTwitter #lcsm #MedTwitter

Oncology Brothers

15,115 просмотров • 2 месяцев назад

Treatment Algorithm: Metastatic Non-Small Cell Lung cancer with 🎯 mutations in 1L w/ Eric K. Singhi, MD ✅ 1L tx options ✅ Sequencing ✅ Re-testing for mutations Full 🗣️: ⭐️ OncBrothers & OncUpdates Website ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm #MedX
1:26
OncBrothers's profile picture

Treatment Algorithm: Metastatic Non-Small Cell Lung cancer with 🎯 mutations in 1L w/ Eric K. Singhi, MD ✅ 1L tx options ✅ Sequencing ✅ Re-testing for mutations Full 🗣️: ⭐️ OncBrothers & OncUpdates Website ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm #MedX

Oncology Brothers

11,844 просмотров • 2 месяцев назад

Zongertinib is now approved for Her2+ NSCLC based off Beamion Lung-1! We had a chance to 🗣️ Her2 testing, trial, findings, AEs and sequencing w/ Joshua Sabari, MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm OncUpdates
1:11
OncBrothers's profile picture

Zongertinib is now approved for Her2+ NSCLC based off Beamion Lung-1! We had a chance to 🗣️ Her2 testing, trial, findings, AEs and sequencing w/ Joshua Sabari, MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm OncUpdates

Oncology Brothers

25,876 просмотров • 11 месяцев назад

Treatment Algorithm series: Small Cell #LungCancer w/ Ticiana Batista (Leal) ✅ Limited Stage ✅ Extensive Stage ✅ Role of PCI ✅ Upcoming data at #ASCO25 Full discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates
1:01
OncBrothers's profile picture

Treatment Algorithm series: Small Cell #LungCancer w/ Ticiana Batista (Leal) ✅ Limited Stage ✅ Extensive Stage ✅ Role of PCI ✅ Upcoming data at #ASCO25 Full discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates

Oncology Brothers

29,738 просмотров • 1 год назад

Treatment Algorithm series: mNSCLC w/ actionable mutations in 1L with Susan Combs Scott, MD ✅ EGFR ✅ ALK ✅ ROS1/BRAF/RET/NTRK/MetExon14 Full discussion: ⭐️ ⭐️ “Oncology Brothers” podcast #lcsm #OncTwitter #LungCancer OncUpdates
1:09
OncBrothers's profile picture

Treatment Algorithm series: mNSCLC w/ actionable mutations in 1L with Susan Combs Scott, MD ✅ EGFR ✅ ALK ✅ ROS1/BRAF/RET/NTRK/MetExon14 Full discussion: ⭐️ ⭐️ “Oncology Brothers” podcast #lcsm #OncTwitter #LungCancer OncUpdates

Oncology Brothers

29,772 просмотров • 1 год назад

Treatment Algorithm series: Early stage NSCLC w/ Deepa Rangachari, MD, FASCO ✅ Resectable disease ✅ Role of NGS early on ✅ Stage III unresectable disease Full discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates
1:14
OncBrothers's profile picture

Treatment Algorithm series: Early stage NSCLC w/ Deepa Rangachari, MD, FASCO ✅ Resectable disease ✅ Role of NGS early on ✅ Stage III unresectable disease Full discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates

Oncology Brothers

26,482 просмотров • 1 год назад

ToxCheck series: Common anti-EGFR drugs we use for mEGFR non-small cell #LungCancer w/ gilberto lopes ✅ Afatinib ✅ Osimertinib ✅ Amivantamab + Lazertinib Full discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates
1:19
OncBrothers's profile picture

ToxCheck series: Common anti-EGFR drugs we use for mEGFR non-small cell #LungCancer w/ gilberto lopes ✅ Afatinib ✅ Osimertinib ✅ Amivantamab + Lazertinib Full discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates

Oncology Brothers

28,555 просмотров • 1 год назад

Lung Cancer Highlights from #ESMO25 with Rami Manochakian MD, FASCO Cancer Education ✅ #MDTBridge ✅ #FLAURA2 ✅ #SOHO01 ✅ #BeamionLung01 Full Discussion: - - Also on “Oncology Brothers” podcast #OncTwitter #lcsm ESMO - Eur. Oncology OncUpdates
1:07
OncBrothers's profile picture

Lung Cancer Highlights from #ESMO25 with Rami Manochakian MD, FASCO Cancer Education ✅ #MDTBridge ✅ #FLAURA2 ✅ #SOHO01 ✅ #BeamionLung01 Full Discussion: - - Also on “Oncology Brothers” podcast #OncTwitter #lcsm ESMO - Eur. Oncology OncUpdates

Oncology Brothers

18,803 просмотров • 9 месяцев назад

ToxCheck: AEs for ADCs approved in Lung Cancer & how to manage them with Jacob sands: ✅ TDXd: HER2+ ✅ DatoDXd: EGFR+ ✅ TelisoV: C-MET Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter OncUpdates OncoAlert #lcsm
1:28
OncBrothers's profile picture

ToxCheck: AEs for ADCs approved in Lung Cancer & how to manage them with Jacob sands: ✅ TDXd: HER2+ ✅ DatoDXd: EGFR+ ✅ TelisoV: C-MET Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter OncUpdates OncoAlert #lcsm

Oncology Brothers

15,258 просмотров • 7 месяцев назад

Part 2/3 on SCLC! Here we discuss AEs and management of our available options in Extensive Stage small cell w/ Misty Dawn Shields Full 📢 🌟 🌟 🌟Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #lcsm #CME
0:54
OncBrothers's profile picture

Part 2/3 on SCLC! Here we discuss AEs and management of our available options in Extensive Stage small cell w/ Misty Dawn Shields Full 📢 🌟 🌟 🌟Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #lcsm #CME

Oncology Brothers

17,402 просмотров • 11 месяцев назад

Lurbinectedin is now approved in 1L for ES-SCLC based off #IMForte! We had a chance to discuss the trial, findings, AE's and management w/ Isabel Preeshagul Stephen V Liu, MD & Ticiana Batista (Leal) Full 🗣️: ⭐️ ⭐️ On “Oncology Brothers” podcast #OncTwitter #lcsm
0:58
OncBrothers's profile picture

Lurbinectedin is now approved in 1L for ES-SCLC based off #IMForte! We had a chance to discuss the trial, findings, AE's and management w/ Isabel Preeshagul Stephen V Liu, MD & Ticiana Batista (Leal) Full 🗣️: ⭐️ ⭐️ On “Oncology Brothers” podcast #OncTwitter #lcsm

Oncology Brothers

15,442 просмотров • 10 месяцев назад